Works matching AU Fox, Robert J
Results: 123
Disability independent of cerebral white matter demyelination in progressive multiple sclerosis.
- Published in:
- Acta Neuropathologica, 2024, v. 148, n. 1, p. 1, doi. 10.1007/s00401-024-02796-w
- By:
- Publication type:
- Article
Technical Note: Retrospective reduction in systematic differences across scanner changes by accounting for noise floor effects in diffusion tensor imaging.
- Published in:
- Medical Physics, 2018, v. 45, n. 9, p. 4171, doi. 10.1002/mp.13088
- By:
- Publication type:
- Article
A double‐blind, randomized, placebo‐controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing‐remitting multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 7, p. 977, doi. 10.1002/acn3.51574
- By:
- Publication type:
- Article
Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 1, p. 111, doi. 10.1002/acn3.51251
- By:
- Publication type:
- Article
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
- Published in:
- Annals of Clinical & Translational Neurology, 2015, v. 2, n. 2, p. 103, doi. 10.1002/acn3.148
- By:
- Publication type:
- Article
Refining the treatment of women with unstable angina-A randomized, double-blind, comparative safety and efficacy evaluation of integrelin™ versus aspirin in the management of unstable angina.
- Published in:
- Clinical Cardiology, 1996, v. 19, n. 11, p. 869, doi. 10.1002/clc.4960191106
- By:
- Publication type:
- Article
Web-Based Self-Management for Patients with Multiple Sclerosis: A Practical, Randomized Trial.
- Published in:
- Telemedicine & e-Health, 2011, v. 17, n. 1, p. 5, doi. 10.1089/tmj.2010.0133
- By:
- Publication type:
- Article
Comparing the Brief Assessment of Cognitive Health and Montreal Cognitive Assessment: Test‐retest reliability and sensitivity to cognitive change in older adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S10, p. 1, doi. 10.1002/alz.094295
- By:
- Publication type:
- Article
A passive electronic medical record‐based cognitive risk calculator predicts neuropsychological performance in older adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S10, p. 1, doi. 10.1002/alz.094254
- By:
- Publication type:
- Article
A passive electronic medical record‐based cognitive risk calculator predicts neuropsychological performance in older adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S5, p. 1, doi. 10.1002/alz.089480
- By:
- Publication type:
- Article
Comparing the Brief Assessment of Cognitive Health and Montreal Cognitive Assessment: Test‐retest reliability and sensitivity to cognitive change in older adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.090995
- By:
- Publication type:
- Article
A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.
- Published in:
- Neurological Research, 2012, v. 34, n. 8, p. 810, doi. 10.1179/1743132812Y.0000000071
- By:
- Publication type:
- Article
Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 9, p. 5093, doi. 10.1007/s00415-022-11166-z
- By:
- Publication type:
- Article
Overcoming barriers to informed consent in neurological research: Perspectives from a national survey.
- Published in:
- Research Ethics, 2023, v. 19, n. 1, p. 42, doi. 10.1177/17470161221131497
- By:
- Publication type:
- Article
Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis.
- Published in:
- Drugs, 2018, v. 78, n. 15, p. 1549, doi. 10.1007/s40265-018-0984-5
- By:
- Publication type:
- Article
T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.
- Published in:
- Annals of Neurology, 2013, v. 73, n. 5, p. 637, doi. 10.1002/ana.23860
- By:
- Publication type:
- Article
Cortical remyelination: A new target for repair therapies in multiple sclerosis.
- Published in:
- Annals of Neurology, 2012, v. 72, n. 6, p. 918, doi. 10.1002/ana.23693
- By:
- Publication type:
- Article
Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 3, p. 445, doi. 10.1002/ana.22337
- By:
- Publication type:
- Article
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial.
- Published in:
- Annals of Neurology, 2008, v. 63, n. 3, p. 395, doi. 10.1002/ana.21363
- By:
- Publication type:
- Article
Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
- Published in:
- Annals of Neurology, 2007, v. 62, n. 3, p. 219, doi. 10.1002/ana.21113
- By:
- Publication type:
- Article
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.
- Published in:
- Annals of Neurology, 2006, v. 59, n. 3, p. 478
- By:
- Publication type:
- Article
Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy.
- Published in:
- Multiple Sclerosis (13524585), 2010, v. 16, n. 11, p. 1335, doi. 10.1177/1352458510377334
- By:
- Publication type:
- Article
Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.
- Published in:
- Multiple Sclerosis (13524585), 2005, v. 11, n. 2, p. 140, doi. 10.1191/1352458505ms1142oa
- By:
- Publication type:
- Article
Mitoxantrone as a potential therapy for primary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2004, v. 10, p. 58, doi. 10.1191/1352458504ms1032oa
- By:
- Publication type:
- Article
Mitoxantrone as a potential therapy for primary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2004, v. 10, n. 1S, p. S58, doi. 10.1177/135245850401000110
- By:
- Publication type:
- Article
Mitoxantrone as a potential therapy for primary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2004, v. 10, n. 3S, p. S58, doi. 10.1191/1352458504ms1032oa
- By:
- Publication type:
- Article
Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label Study
- Published in:
- CNS Drugs, 2023, v. 37, n. 3, p. 275, doi. 10.1007/s40263-022-00982-6
- By:
- Publication type:
- Article
Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2025, v. 31, n. 3, p. 314, doi. 10.1177/13524585241310104
- By:
- Publication type:
- Article
DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.
- Published in:
- Multiple Sclerosis Journal, 2025, v. 31, n. 2, p. 159, doi. 10.1177/13524585241303489
- By:
- Publication type:
- Article
Using serum neurofilament-light in clinical practice: Growing enthusiasm that may need bridling.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 3, p. 369, doi. 10.1177/13524585231224702
- By:
- Publication type:
- Article
Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 35, doi. 10.1177/13524585231213164
- By:
- Publication type:
- Article
Effect of ibudilast on thalamic magnetization transfer ratio and volume in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 10, p. 1257, doi. 10.1177/13524585231187289
- By:
- Publication type:
- Article
The impact of cigarette smoking on cognitive processing speed and brain atrophy in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 846, doi. 10.1177/13524585231172490
- By:
- Publication type:
- Article
The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 3, p. 427, doi. 10.1177/13524585221140270
- By:
- Publication type:
- Article
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1591, doi. 10.1177/13524585221083194
- By:
- Publication type:
- Article
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1526, doi. 10.1177/13524585221076717
- By:
- Publication type:
- Article
Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 801, doi. 10.1177/13524585211037909
- By:
- Publication type:
- Article
DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity – Commentary.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 2, p. 187, doi. 10.1177/13524585211049073
- By:
- Publication type:
- Article
Sensitivity of T1/T2-weighted ratio in detection of cortical demyelination is similar to magnetization transfer ratio using post-mortem MRI.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 2, p. 198, doi. 10.1177/13524585211014760
- By:
- Publication type:
- Article
Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 16, doi. 10.1177/13524585211059766
- By:
- Publication type:
- Article
Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray–white matter junction correlates with iron-enriched macrophages.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2159, doi. 10.1177/1352458521999651
- By:
- Publication type:
- Article
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 13, p. 2014, doi. 10.1177/1352458520986956
- By:
- Publication type:
- Article
Comparative responsiveness of the health utilities index and the RAND-12 for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 11, p. 1781, doi. 10.1177/1352458520981370
- By:
- Publication type:
- Article
Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 10, p. 1564, doi. 10.1177/1352458520971819
- By:
- Publication type:
- Article
Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 9, p. 1384, doi. 10.1177/1352458520964409
- By:
- Publication type:
- Article
Patient reported outcomes and performance metrics at diagnosis of secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 5, p. 742, doi. 10.1177/1352458520936214
- By:
- Publication type:
- Article
New applications for independent activities of daily living in measuring disability in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 1, p. 97, doi. 10.1177/1352458519898591
- By:
- Publication type:
- Article